Mutual of America Capital Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.08M | Sell |
38,971
-353
| -0.9% | -$9.74K | 0.01% | 959 |
|
2025
Q1 | $1.11M | Sell |
39,324
-1,187
| -3% | -$33.7K | 0.01% | 976 |
|
2024
Q4 | $1.68M | Sell |
40,511
-1,087
| -3% | -$45.2K | 0.02% | 907 |
|
2024
Q3 | $2.78M | Sell |
41,598
-399
| -1% | -$26.7K | 0.03% | 755 |
|
2024
Q2 | $4.99M | Sell |
41,997
-1,448
| -3% | -$172K | 0.05% | 446 |
|
2024
Q1 | $4.63M | Sell |
43,445
-912
| -2% | -$97.2K | 0.05% | 515 |
|
2023
Q4 | $4.41M | Sell |
44,357
-1,948
| -4% | -$194K | 0.05% | 525 |
|
2023
Q3 | $4.78M | Sell |
46,305
-832
| -2% | -$85.9K | 0.06% | 421 |
|
2023
Q2 | $5.73M | Sell |
47,137
-117
| -0.2% | -$14.2K | 0.07% | 384 |
|
2023
Q1 | $7.26M | Buy |
47,254
+79
| +0.2% | +$12.1K | 0.09% | 261 |
|
2022
Q4 | $8.47M | Buy |
47,175
+621
| +1% | +$112K | 0.11% | 205 |
|
2022
Q3 | $5.51M | Sell |
46,554
-597
| -1% | -$70.6K | 0.07% | 351 |
|
2022
Q2 | $6.74M | Buy |
47,151
+118
| +0.3% | +$16.9K | 0.09% | 287 |
|
2022
Q1 | $8.1M | Buy |
47,033
+507
| +1% | +$87.3K | 0.09% | 287 |
|
2021
Q4 | $11.8M | Buy |
46,526
+474
| +1% | +$120K | 0.12% | 167 |
|
2021
Q3 | $17.7M | Buy |
46,052
+43,273
| +1,557% | +$16.7M | 0.18% | 81 |
|
2021
Q2 | $653K | Sell |
2,779
-210
| -7% | -$49.3K | 0.01% | 1108 |
|
2021
Q1 | $391K | Sell |
2,989
-91
| -3% | -$11.9K | ﹤0.01% | 1187 |
|
2020
Q4 | $322K | Buy |
+3,080
| New | +$322K | ﹤0.01% | 1184 |
|